Download presentation
Presentation is loading. Please wait.
Published byDamon Carter Modified over 9 years ago
1
STREPTOCOCCI
2
General character Gram positive cocci arranged in chains Catalase test negative Fastidious Facultative anaerobes Penicillin sensitive (Streptococcus faecalis ) Resistant to AG (GENTAMICIN )
5
GROUP A STREPT STREPTOCOCCUS PYOGENES
6
Most important pathogen Distinguished by bacitracin test (sensitive) Some are capsulated (hyaluronic acid)
7
epidemiology Acquired through infected respiratory droplet Direct contact _ Skin, hand Indirect contact _contaminated objects Spread enhanced by poverty overcrowding poor ventilation
8
Source of infection A - Patient with active disease – tonsillitis Convalescent carriers – throat B - Asymptomatic carriers (20% -school children ) – throat Prevalent in children – 3 – 8 yrs
9
VIRULENCE FACTORES A- CELL ASSOCIATED 1- M protein (antiphagocytic) - originates from cytoplasmic membrane produces protective type specific abs 2- lipoteichoic acid adhesion factor for attachment 3- hyaluronic acid capsule - antiphagocytic
10
3- STREPTOKINASE (fibrinolysin) Thrombotic disease – coronary thrombosis 4- DNAases A, B, C, D. AntiDNAase B - DIAGNOSE SKIN infections 5- HYALURONIDASE – spread factor 6- LIPOPROTEINASE – opacity factor
11
B- EXTRACELLULAR PRODUCTS 1- SREPTOLYSINS OR HAEMOLYSIN Streptolysin o antigenic, ASO, oxygen labile Streptolysin s oxygen stable, non antigenic 2- Erythrogenic toxin (SPE ) SUPERANTIGEN Bacteriophage – 3 types, A – B- C. SCARLET FEVER B- EXTRACELLULAR PRODUCTS
12
DISEASES A - SAPURATIVE A- SAPURATIVE 1- TONSILITIS / PHARINGITIS 2- PERITONSILAR ABSCESS(QUINSY) 3- OTITIS MEDIA 4- ADENITIS 5- IMPETIGO (PYODERMA) 6- SCARLET FEVER 7- CELLULITIS 8- PUERPERAL SEPSIS 9- INVASIVE SOFT TISSUE INFECTIOS NECROTISING FASCITIS, MYOSITIS, TSS 10 - BACTERIMIA
16
B- NON- SUPPURATIVE (DELAYED SEQUELAE) 1- RHEUMATIC FEVER : autoimmune disease follows throat infection only recur (M – SEROTYPES) 2- ACUTE GLOMERULONEPHRITIS Ag – Ab complexes May follow both throat or skin infection NO recurrence B-NON SUPPURATIVE (DELAED SEQUELAE)
17
LABORATORY DIAGNOSIS SPECIMEN THROAT SWAB PUS WOUND BLOOD ASPIRATES SERUM – SEROLOGY : ASO TITRE
18
MICROSCOPY GRAM – STAIN – GRAM-POSITIVE COCCI IN CHAIN – USELESS IN THROAT SWAB
19
CULTURE - IDENTIFICATION BLOOD-AGAR (AEROBIC- ANAEROBIC) BETA- HAEMOLYSIS (COMPLETE ) ID – BACITRACIN SENSITIVITY – LANCEFIELDS GROUPING (CELL WALL CHO- Ag) – STREPTEX
25
SEROLOGY ASO-TITRE – RHEUMATIC FEVER – ACUTE GLOMERULONEPHRITIS Anti-DNAase B – RECENT GROUP -A INFECTIONS (SKIN)
26
TREATMENT PENICILLIN – 10 DAYS ALLERGY- – ERYTHROMYCIN – CEPHALOSPORINS CEPHRADIN CEFUROXIME
27
GROUP C AND G STREPT. SORE THROAT SKIN INFECTION WOUND INFECTION SOFT – TISSUE GENITAL – INFECTION CELLULITIS SEPTICAEMIA
28
GROUP-B STREPTOCOCCUS (SREPT. AGALACTIAE) RESERVOIR- COLON (RECTUM) 10-40 % FEMALE. CARRIER (VAGINA) 70% - NEOBORN – COLONISED DURING BIRTH < 1% GET INVIASIVE INFECTION
29
DISEASES A – EARLY ONSET (24 – 48 h ) RISK – FACTORS RUPTURED MEMBRANES (>18h PREMATURITY PROM (< 37 WEEKS) MULTIPLE BIRTH (TWINS) LOW BIRTH WEIGHT
30
CLINICAL PICTURE RESPIRATORY DISTRESS SYNDROME SEPTICAEMIA MENINGITIS MORTALITY :
31
B- LATE – ONSET HOSPITAL- AQUIRED (NOSOCOMIAL) MENNGITIS IN FULL – TERM NEONAT. BETTER PROGNOSIS MORTALITY
32
DIAGNOSIS CLINICAL LATEX – AGGLUTINATION CULTURE ID – CAMP – TEST – STREPTEX (GROUPING)
33
INFECTIONS IN ADULTS POST-PARTUM SEPSIS CHORIOAMNIONITIS IMMUNOCOMPROMISED – SEPSIS – CELLULITIS – ARTHRITIS – PNEUMONIA
34
TREATMENT PREVENTION PENICILLIN OR AMPICILLIN + GENTAMICIN SCREEN- PREGNANT W. (35-37 W) CARRIER – PROPHYLAXIES – IV- PENICILLIN – AT LABOUR
35
GROUP – D STREPT. NORMAL INTESTINAL FLORA A- ENTEROCOCCI GROW IN 40% BILE-ACID,6.5% NACL PENICILLIN RESISTENT AMPICILLIN SENSITIVE - E. FAECALIS : 80% - 90% INFECTI. - E. FAECIUM : MANY AMPICILLIN R. B- NON-ENTEROCOCCI PENICILLIN SENSETIVE STREPT. BOVIS
36
DISEASES URINARY TRACT INFECTIONS ENDOCARDITIS WOUND INFECTIONS TREATMENT AMPICILLIN + GENTAMICIN VANCOMYCIN ( VRE )
37
ALPHA – HEMOLYTIC STREPTOCOCCI S.PNEUMONIAE VIRIDANS
38
S.PNEUMONIAE PNEUMONIA BACTEREMIA MENINGITIS SEPTIC ARTHRITIS PERITONITIS OTITIS MEDIA SINUSITIS CONJUNCTIVITIS BRONCITIS
39
GRAM POSITIVE DIPLOCOCCI POLYSACCHARIDE CAPSULES (85) ANTIPHAGOSITIC OPSONIZING ANTIBODIES ANTCAPSULAR AB. ARE PROTECTIVE PNEUMOLYSIN
40
RISK FACTORS CEREBRAL IMPAIRMENT VIRAL INFECTION OLD AGE HEART FAILURE SPLENECTOMY SCA, MULTIPLE MYLOMA, HIV SKULL FRACTURE
41
DIAGNOSIS SPUTUM, BLOOD, CSF MICROSCOPY QUELLUNG REACTION BILE SOLUBLE OPTOCHIN SENSETIVE BLOOD CULTURE + IN 15% LATEX AGGLUTINATION SENSETIVITY TEST
42
TREATMENT, PREVENTION CEFTRIXONE + VANCOMYCIN PENICILLIN ERYTHROMYCIN CLINDAMYCIN VACCIN
43
VIRIDANS NORMAL FLORA – OROPHARYNX – SKIN – GIT
44
ENDOCARDITIS FEVER, ANEMIA, HEART MURMUR S. MUTANS –POLYSACCHARIDES (DEXTRAN) – DENTAL CARIES S.SANGUIS S.SALIVARIUS S.MITIS S. BOVIS ( CA. COLON ) S.INTERMEDIUS ( MILLERI) – DENTAL, BRAIN, ABDOMINAL ABSCESSES
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.